Gerresheimer invests in Portal's needle-free drug delivery, teeing Takeda partner up to advance tech
Gerresheimer has signed up to support development of Portal Instruments’ needle-free drug delivery platform, taking a stake in its new partner and agreeing to throw its weight behind a technology that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results